Brooks Laboratories Limited Share Price and Company Fundamentals
Last traded: Last Friday at 9:58 AM
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye/ear drops. The company was incorporated in 2002 and is based in Mumbai, India.
|Industry / Sector||Drug Manufacturers—Specialty & Generic / Healthcare|
|Full time employees||335|
|Mailing address||201, The Summit Business Park Behind Guru Nanak Petrol Pump Off. AndheriKurla Road Andheri (East) Mumbai 400093 India|
|Phone / Fax||91 22 6193 3100 /|
Brooks Laboratories Limited paid ₹0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BROOKS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
BROOKS's forward dividend amount is ₹ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
As of Dec 2022, following are the company executives and directors listed on Brooks Laboratories Limited.
|Mr. Prashant Rathi||Chief Financial Officer||30||2.5M|
|Mr. Manpreet Singh Naroo||Technical Director & Whole Time Director||50|
|Ms. Jai Vaidya||Company Sec. & Compliance Officer|
|Mrs. Saras Gupta||Gen. Mang. of Marketing||47|
|Mrs. Rajni Ranchal||Gen. Mang. of Production||52|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Brooks Laboratories Limited is and its enterprise value is .
The BROOKS's stocks Beta value is 1.48 making it 48% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Brooks Laboratories Limited (NSE:BROOKS) Frequently Asked Questions
1. What is Brooks Laboratories Limited's Stock Symbol?
Brooks Laboratories Limited trades on NSE under the ticker symbol "BROOKS".
2. What is Brooks Laboratories Limited's stock price today?
One share of BROOKS stock can currently be purchased for approximately ₹117.8.
3. How can I contact Brooks Laboratories Limited?
Brooks Laboratories Limited's mailing address is 201, The Summit Business Park Behind Guru Nanak Petrol Pump Off. AndheriKurla Road Andheri (East) Mumbai 400093 India. The company can be reached via phone at 91 22 6193 3100.
4. What is Brooks Laboratories Limited's official website?
The official website of Brooks Laboratories Limited is https://www.brookslabs.net.